Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas Reed Md currently holds 3,237,711 shares of TETRALOGIC PHARMACEUTICALS CORP (TLOG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Reed Md has been a net seller of TLOG stock. They have purchased $3.0M and sold $41.2M worth of shares.
Douglas Reed Md's most recent insider trade was on May 30, 2018, when they sold 41,710 shares at $48.00 per share.
Douglas Reed Md serves as Executive at TETRALOGIC PHARMACEUTICALS CORP (TLOG). They have executed 41 insider transactions totaling $44.2M over their tenure at the company.
Douglas Reed Md holds the position of Executive at TETRALOGIC PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Douglas Reed Md has shown a selling trading pattern, with $3.0M in total purchases and $41.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas Reed Md was on May 30, 2018, when they sold $36.4M worth of GTHX shares. This transaction involved 758,290 shares at $48.00 per share.
Douglas Reed Md currently owns 3,237,711 shares of TETRALOGIC PHARMACEUTICALS CORP (TLOG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas Reed Md's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas Reed Md has 41 Form 4 filings on record as an insider at TETRALOGIC PHARMACEUTICALS CORP.
Set alerts for Douglas Reed Md and 40,000+ other insiders.